Bluejay Diagnostics Inc. Gains 53.23%

Bluejay Diagnostics Inc. (BJDX:NASDAQ) jumped higher at $4.75, a gain of 53.2%. On Wed, Sep 20, 2023, BJDX:NASDAQ touched a New 2-Week High of $4.75. The stock appeared on our News Catalysts scanner on Mon, Aug 28, 2023 at 02:02 PM in the 'BIOTECH' category. From Wed, Sep 06, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Wed, Sep 20, 2023 at $5.95 with a volume of 36M+.
About Bluejay Diagnostics Inc. (BJDX:NASDAQ)
Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide...
Top 10 Gainers:
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- MSP Recovery Inc. (LIFW:NASDAQ), 64.14%
- Fresh Tracks Therapeutics Inc Com (New) (FRTX:NASDAQ), 54.48%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 53.23%
- Evaxion Biotech A/S (EVAX:NASDAQ), 41.67%
- Avinger, Inc. (AVGR:NASDAQ), 31.96%
- Histogen Inc. (HSTO:NASDAQ), 26.58%
- TradeUP Acquisition Corp. (UPTD:NASDAQ), 26.42%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 25.71%
- Esports Technologies Inc. (EBET:NASDAQ), 24.76%